Prothena Corp PLC Sustainability Reports

Prothena Corporation plc is a late-stage clinical biotechnology company focused on the research and development of novel therapeutic therapies for neurodegenerative and rare peripheral amyloid diseases. Its expertise centers primarily around protein dysregulation and targeting misfolded proteins.

Sector: Manufacturing

Country: Ireland

Exchange: Nasdaq

LEI: 5299009ZXQ8NIIJ8OL30

FIGI: BBG00393H6N0

12 reports from 2014 to 2025

• Prothena Corp PLC 2025 Directors' Report and Consolidated Financial Statements
• Prothena Corp PLC 2024 Directors' Report and Consolidated Financial Statements
• Prothena Corp PLC 2023 Directors' Report and Consolidated Financial Statements
• Prothena Corp PLC 2022 Directors' Report and Consolidated Financial Statements
• Prothena Corp PLC 2021 Directors' Report and Consolidated Financial Statements